https://arxiv.org/api/cBv9RSS0HF0mWjwRXzNQsa36b7o 2026-06-19T06:24:41Z 1596 540 15 http://arxiv.org/abs/2205.00027v1 2022-04-29T18:12:51Z

It is widely acknowledged that there is a diversity problem in genomics stemming from the vast underrepresentation of non-European genetic ancestry populations. While many challenges exist to address this gap, a major complicating factor is the misalignment between (1) how society defines and labels individuals; (2) how populations are defined for research; and (3) how research findings are translated to benefit human health. Recent conversations to address the lack of clarity in terminology in genomics have largely focused on ontologies that acknowledge the difference between genetic ancestry and race. Yet, these ontological frameworks for ancestry often follow the subjective discretization of people, normalized by historical racial categories; this perpetuates exclusion at the expense of inclusion. In order to make the benefits of genomics research accessible to all, standards around race, ethnicity, and genetic ancestry must deliberately and explicitly address multiracial, genetically admixed individuals who make salient the limitations of discrete categorization in genomics and society. Starting with the need to clarify terminology, we outline current practices in genomic research and translation that fail those who are 'binned' for failing to fit into a specific bin. We conclude by offering concrete solutions for future research in order to share the benefits of genomics research with the full human population.

2022-04-29T18:12:51Z Daphne O. Martschenko Center for Biomedical Ethics, Stanford University School of Medicine, Stanford CA Hannah Wand Department of Cardiology, Stanford University School of Medicine, Stanford CA Jennifer L. Young Center for Biomedical Ethics, Stanford University School of Medicine, Stanford CA Center for Genetic Medicine, Northwestern University, Feinberg School of Medicine, Chicago IL Genevieve L. Wojcik Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore MD http://arxiv.org/abs/2204.10672v1 2022-04-21T14:01:00Z

The use of population descriptors like race, ethnicity, and ancestry in science, medicine and public health has a long, complicated, and at times dark history, particularly for genetics, given the field's perceived importance for understanding between-group differences. The historical and potential harms that come with irresponsible use of these categories suggests a clear need for definitive guidance about when and how they can be used appropriately. However, while many prior authors have provided such guidance, no established consensus exists, and the extant literature has not been examined for implied consensus and sources of disagreement. Here we present the results of a systematic review of published normative recommendations regarding the use of population categories, particularly in genetics research. Following PRISMA guidelines, we extracted recommendations from n=121 articles matching inclusion criteria. Articles were published consistently throughout the time period examined and in a broad range of journals, demonstrating an ongoing and interdisciplinary perceived need for guidance. Examined recommendations fall under one of eight themes identified during analysis. Seven are characterized by broad agreement across articles; one, Appropriate definitions of population categories and contexts for use, revealed substantial fundamental disagreement among articles. While many articles focus on the inappropriate use of race, none fundamentally problematize ancestry. This work can be a resource to researchers looking for normative guidance on the use of population descriptors, and can orient authors of future guidelines to this complex field, contributing to the development of more effective future guidelines for genetics research.

2022-04-21T14:01:00Z Madelyn Mauro Danielle S. Allen Bege Dauda Santiago J. Molina Benjamin M. Neale Anna C. F. Lewis http://arxiv.org/abs/2204.03728v1 2022-04-07T20:42:43Z

Eight experiments were conducted to test an oregano-essential-oil-based product (PRO) on performance, gut health, and nutrient absorption capacity in broilers. The first three, up to 14d and without specific challenges, tested the effects on intestinal histology, skeletal integrity, and growth. Other two experiments, up to 28d birds were challenged to induce feed passage syndrome (STR) and test the effect on the antioxidant status and performance, contrasting later the results under a natural challenge in commercial conditions. Finally, in two other experiments, up to 21 d, birds challenged with coccidia were tested to determine the effects on coccidiosis, nutrient digestibility, and feed efficiency (FCR). Corn-soybean-fish meal diets were used. Under healthy conditions, PRO effects were observed on intestinal villus height and surface area, mucosa density and structure, villus to crypt ratio, goblet cells density, mucus production, body weight gain, and FCR (P<0.04), and carcass yield and bone density (P<0.08). Birds affected by STR showed effects (P<0.05) on superoxide dismutase activity, bodyweight gain, FCRE, non-normal feces frequency, bursal diameter, and dysbacteriosis. Birds affected by coccidia showed effects on cocci-positive ratio, cocci microscopic score, oocysts count, bursal diameter, body weight gain, FCR, apparent digestibility of dry matter and crude protein, protein and energy efficiencies (P<0.01), and nitrogen apparent retention (P<0.07). Results showed PRO added value to the diet favoring feed efficiency and performance.

2022-04-07T20:42:43Z Diego Martinez http://arxiv.org/abs/2204.00960v1 2022-04-03T00:49:54Z

The recent opinion article "A decade of molecular cell atlases" by Stephen Quake narrates the incredible single-cell genomics technology advances that have taken place over the last decade, and how they have translated to increasingly resolved cell atlases. However the sequence of events described is inaccurate and contains several omissions and errors. The errors are corrected in this note.

2022-04-03T00:49:54Z Lior Pachter http://arxiv.org/abs/2203.14201v2 2022-03-30T15:07:29Z

Nymphaea caerulea is a valuable freshwater aquatic plant, not only because of its ornamental value but also its extractions for chemical and medical uses. It is necessary to store its seeds as backup resources. Cryopreservation is the reliable, cost-effective method for long-term preservation of botanical genetic banks, especially for recalcitrant plants. In this study, we demonstrated that due to unable to tolerate desiccation and low-temperature, N. caerulea is recalcitrant. Since viability was lost before 6 months storage, N. caerulea seeds were not appropriate to long-term store by traditional storage method. The only way to long-term store N. caerulea seeds is cryopreservation. However, Plant Vitrification Solution 3 (PVS3; 50% w/v sucrose, 50% w/v glycerol), a commonly used plant vitrification solution, was ineffective on N. caerulea seeds cryopreservation. The maximum survival rate of cryopreserved seeds treated by PVS3 was only 23%. Oxidative stress induced by reactive oxygen species (ROS) accumulation within seeds was the reason to cause inefficiency of PVS3 treated seeds cryopreservation. We developed a new plant vitrification solution (PVS+), by adding glutathione (GSH) into PVS3. PVS+ rescued the inefficiency by decreasing ROS accumulation and elevated survival rate of cryopreserved seeds to 97%. Our results showed some inefficiencies of plant tissue cryopreservation may be caused by ROS-induced oxidative stress. Antioxidants can reduce ROS-induced oxidative stress and improve seeds survival after cryopreservation. In conclusion, N. caerulea seeds were identified as recalcitrant and successfully cryopreserved. Suppressing ROS accumulation during cryopreservation may be a potential strategy to improve survival rate of recalcitrant seeds after cryopreservation.

2022-03-27T03:49:43Z This publish was a mistake Chung-Hao Lee http://arxiv.org/abs/2203.13193v1 2022-03-23T13:23:43Z

The COronaVIrus Disease 2019 (COVID-19) pandemic that has had the world in its grip from the beginning of 2020, has resulted in an unprecedented level of public interest and media attention on the field of mathematical epidemiology. Ever since the disease came to worldwide attention, numerous models with varying levels of sophistication have been proposed; many of these have tried to predict the course of the disease over different time-scales. Other models have examined the efficacy of various policy measures that have been adopted (including the unparalleled use of "lockdowns") to contain and combat the disease. This multiplicity of models may have led to bewilderment in many quarters about the true capabilities and utility of mathematical modeling. Here we provide a brief guide to epidemiological modeling, focusing on how it has emerged as a tool for informed public-health policy-making and has in turn, influenced the design of interventions aimed at preventing disease outbreaks from turning into raging epidemics. We show that the diversity of models is somewhat illusory, as the bulk of them are rooted in the compartmental modeling framework that we describe here. While their basic structure may appear to be a highly idealized description of the processes at work, we show that features that provide more realism, such as the community organization of populations or strategic decision-making by individuals, can be incorporated into such models. We conclude with the argument that the true value of models lies in their ability to test in silico the consequences of different policy choices in the course of an epidemic, a much superior alternative to trial-and-error approaches that are highly costly in terms of both lives and socio-economic disruption.

2022-03-23T13:23:43Z 26 pages, 7 figures, to appear in "COVID-19 and Global Grand Challenges on Health, Innovation and Economy" Sitabhra Sinha http://arxiv.org/abs/2203.11402v1 2022-03-22T00:50:11Z

Vitamin K is vital for normal blood coagulation, and may influence bone, neurological and vascular health. Data on the vitamin K content of Australian foods are limited, preventing estimation of vitamin K intakes in the Australian population. We measured phylloquinone (PK) and menaquinone (MK) -4 to -10 in cheese, yoghurt and meat products (48 composite samples from 288 primary samples) by liquid chromatography with electrospray ionisation-tandem mass spectrometry. At least one K vitamer was found in every sample. The greatest mean concentrations of PK, MK-4 and MK-9 were found in lamb liver, chicken leg meat and Cheddar cheese, respectively. Cheddar cheese and cream cheese contained MK-5. MK-8 was found in Cheddar cheese only. As the K vitamer profile and concentrations appear to vary considerably by geographical location, Australia needs a vitamin K food composition dataset that is representative of foods consumed in Australia.

2022-03-22T00:50:11Z 23 pages, 2 tables Food Chem. 397:133772 (2022) Eleanor Dunlop Jette Jakobsen Marie Bagge Jensen Jayashree Arcot Liang Qiao Judy Cunningham Lucinda J Black 10.1016/j.foodchem.2022.133772 http://arxiv.org/abs/2009.12773v2 2022-03-14T10:58:22Z

COVID-19 is now a global pandemic, and an effective vaccine may be many months away. Over 100 years ago, Spanish flu fatalities were attenuated when doctors began treating patients with blood plasma donated by recovered (or convalesced) survivors. Passive immunity transfer via administration of convalesced blood product (CBP) appears to represent a readily available and promising avenue for mitigating mortalities, expediting recovery time, and even prophylaxis against the SARS-CoV-2 virus. Here, we review challenges to CBP efficacy, and present a graph theoretical model of transmission dynamics that identifies evolving hubs of COVID-19 cases. Importantly, this model suggests that CBP efficacy may rest on an efficient and distributed global sampling scheme as opposed to CBP pooled from local donors alone.

2020-09-27T07:32:29Z This content is no longer relevant Pamela K. Douglas Farzad V. Farahani David B. Douglas Susan Bookheimer http://arxiv.org/abs/2108.09499v2 2022-02-23T17:06:09Z

The imminent release of tissue atlases combining multi-channel microscopy with single cell sequencing and other omics data from normal and diseased specimens creates an urgent need for data and metadata standards that guide data deposition, curation and release. We describe a Minimum Information about highly multiplexed Tissue Imaging (MITI) standard that applies best practices developed for genomics and other microscopy data to highly multiplexed tissue images and traditional histology.

2021-08-21T12:17:45Z Denis Schapiro Clarence Yapp Artem Sokolov Sheila M. Reynolds Yu-An Chen Damir Sudar Yubin Xie Jeremy L. Muhlich Raquel Arias-Camison Sarah Arena Adam J. Taylor Milen Nikolov Madison Tyler Jia-Ren Lin Erik A. Burlingame Human Tumor Atlas Network Young H. Chang Samouil L Farhi Vésteinn Thorsson Nithya Venkatamohan Julia L. Drewes Dana Pe'er David A. Gutman Markus D. Herrmann Nils Gehlenborg Peter Bankhead Joseph T. Roland John M. Herndon Michael P. Snyder Michael Angelo Garry Nolan Jason R. Swedlow Nikolaus Schultz Daniel T. Merrick Sarah A. Mazzilli Ethan Cerami Scott J. Rodig Sandro Santagata Peter K. Sorger http://arxiv.org/abs/2202.09847v1 2022-02-20T16:07:14Z

Here we examine the evolution of beta-2 microglobulin in terms of its hydropathic shapes, a theoretical construct that has revealed important trends. The dynamics of many proteins are largely driven by interactions between the protein itself and the thin water film that covers it. \b{eta}2m constitutes the basic building unit of the immunoglobulin superfamily; the evolution of its amino acid sequences from chickens to mice to humans provides new information about its multiple functions. Our hydrodynamic method involves concepts of topological shape evolution towards a critical point for optimized functions. The results are in excellent agreement with experiment for the details of the mouse-human evolution, as well as both the dangerous natural amyloid aggregation mutation D76N, and six other DN test mutations.

2022-02-20T16:07:14Z 10 pages, 4 figures J. C. Phillips http://arxiv.org/abs/2202.07782v1 2022-02-15T23:16:36Z

The GFF3 format is a common, flexible tab-delimited format representing the structure and function of genes or other mapped features (https://github.com/The-Sequence-Ontology/Specifications/blob/master/gff3.md). However, with increasing re-use of annotation data, this flexibility has become an obstacle for standardized downstream processing. Common software packages that export annotations in GFF3 format model the same data and metadata in different notations, which puts the burden on end-users to interpret the data model. The AgBioData consortium is a group of genomics, genetics and breeding databases and partners working towards shared practices and standards. Providing concrete guidelines for generating GFF3, and creating a standard representation of the most common biological data types would provide a major increase in efficiency for AgBioData databases and the genomics research community that use the GFF3 format in their daily operations. The AgBioData GFF3 working group has developed recommendations to solve common problems in the GFF3 format. We suggest improvements for each of the GFF3 fields, as well as the special cases of modeling functional annotations, and standard protein-coding genes. We welcome further discussion of these recommendations. We request the genomics and bioinformatics community to utilize the github repository (https://github.com/NAL-i5K/AgBioData_GFF3_recommendation) to provide feedback via issues or pull requests.

2022-02-15T23:16:36Z 23 pages Surya Saha Boyce Thompson Institute, Ithaca, NY Scott Cain Ontario Institute for Cancer Research, Toronto, Canada Ethalinda K. S. Cannon USDA, Agricultural Research Service, Corn, Insects, and Crop Genetics Research Unit Nathan Dunn Truveta, Seattle, WA Andrew Farmer National Center for Genome Resources Zhi-Liang Hu Iowa State University, Ames, IA Gareth Maslen European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, UK Sierra Moxon Lawrence Berkeley National Lab, Berkeley, California, USA Christopher J Mungall Lawrence Berkeley National Lab, Berkeley, California, USA Rex Nelson USDA, Agricultural Research Service, Corn, Insects, and Crop Genetics Research Unit Monica F. Poelchau USDA, Agricultural Research Service, National Agricultural Library http://arxiv.org/abs/2107.10332v9 2022-02-14T04:18:47Z

The early detection of cancer is a challenging problem in medicine. The blood sera of cancer patients are enriched with heterogeneous secretory lipid bound extracellular vesicles (EVs), which present a complex repertoire of information and biomarkers, representing their cell of origin, that are being currently studied in the field of liquid biopsy and cancer screening. Vibrational spectroscopies provide non-invasive approaches for the assessment of structural and biophysical properties in complex biological samples. In this pilot study, multiple Raman spectroscopy measurements were performed on the EVs extracted from the blood sera of 9 patients consisting of four different cancer subtypes (colorectal cancer, hepatocellular carcinoma, breast cancer and pancreatic cancer) and five healthy patients (controls). FTIR (Fourier Transform Infrared) spectroscopy measurements were performed as a complementary approach to Raman analysis, on two of the four cancer subtypes. The AdaBoost Random Forest Classifier, Decision Trees, and Support Vector Machines (SVM) distinguished the baseline corrected Raman spectra of cancer EVs from those of healthy controls (18 spectra) with a classification accuracy of above 90 percent when reduced to a spectral frequency range of 1800 to 1940 inverse cm and subjected to a 50:50 training: testing split. FTIR classification accuracy on 14 spectra showed an 80 percent classification accuracy. Our findings demonstrate that basic machine learning algorithms are powerful applied intelligence tools to distinguish the complex vibrational spectra of cancer patient EVs from those of healthy patients. These experimental methods hold promise as valid and efficient liquid biopsy for artificial intelligence-assisted early cancer screening.

2021-07-21T19:56:33Z 41 pages Applied Intelligence (2022) Abicumaran Uthamacumaran Samir Elouatik Mohamed Abdouh Michael Berteau-Rainville Zu-hua Gao Goffredo Arena 10.1007/s10489-022-03203-1 http://arxiv.org/abs/2202.03425v1 2022-02-05T20:03:41Z

Colorectal cancer refers to the cancer from the dentate line to the junction of rectosigmoid colon, which is one of the most common malignant tumors of the digestive tract. The treatment of colorectal cancer is controversial, so understanding the risk factors and survival factors of colorectal cancer is of great significance for the diagnosis of patients. This study sampled patients with colorectal cancer from the SEER database. The factors affecting the survival of colorectal cancer patients were analysed by combining principal component analysis and competitive risk model, and the survival time of patients was analysed by combining principal component analysis and linear regression. Finally, the data were predicted. The results show that principal component analysis can effectively reduce the number of variables, and the combination of competitive risk model and linear regression model can effectively analyse and predict the data.

2022-02-05T20:03:41Z Boda Xie http://arxiv.org/abs/2011.04636v2 2022-02-01T14:04:01Z

Objective: The design of an Artificial Pancreas (AP) to regulate blood glucose levels requires reliable control methods. Model Predictive Control has emerged as a promising approach for glycemia control. However, model--based control methods require computationally simple and identifiable mathematical models that represent glucose dynamics accurately, which is challenging due to the complexity of glucose homeostasis. Methods: In this work, a simple model is deduced to estimate blood glucose concentration in subjects with Type 1 Diabetes Mellitus (T1DM). Novel features in the model are power--law kinetics for intraperitoneal insulin absorption and a separate glucagon sensitivity state. Profile likelihood and a method based on singular value decomposition of the sensitivity matrix are carried out to assess parameter identifiability and guide a model reduction for improving the identification of parameters. Results: A reduced model with 10 parameters is obtained and calibrated, showing good fit to experimental data from pigs where insulin and glucagon boluses were delivered in the intraperitoneal cavity. Conclusion: A simple model with power--law kinetics can accurately represent glucose dynamics submitted to intraperitoneal insulin and glucagon injections. The reduced model was found to exhibit local practical as well as structural identifiability. Importance: The proposed model facilitates intraperitoneal bi-hormonal model-based closed-loop control in animal trials.

2020-11-09T18:45:51Z IEEE Transactions on Biomedical Engineering 2021 Claudia Lopez-Zazueta Øyvind Stavdahl Anders Lyngvi Fougner 10.1109/TBME.2021.3125839 http://arxiv.org/abs/2112.13044v3 2022-01-28T17:32:38Z

We present an open source model that allows quantitative prediction of the effects of testing on the rate of spread of COVID-19 described by R, the reproduction number, and on the degree of quarantine, isolation and lockdown required to limit it. The paper uses the model to quantify the outcomes of different test types and regimes, and to identify strategies and tests that can reduce the rate of spread and R value by a factor of between 1.67 and 33.3, reducing it to between 60% and 3% of the initial value.

2021-12-24T12:09:37Z 10 pages, 6 figures, in English Mark R Baker Elizabeth L Hawthorne Jessica R Rogge